160 related articles for article (PubMed ID: 4381424)
1. A comparison of haloperidol and Trifluoperazine. (A double-blind, controlled study on chronic schizophrenic outpatients).
Luckey WT; Schiele BC
Dis Nerv Syst; 1967 Mar; 28(3):181-6. PubMed ID: 4381424
[No Abstract] [Full Text] [Related]
2. A double-blind comparison of once-a-day pimozide, trifluoperazine, and placebo in the maintenance care of chronic schizophrenic outpatients.
Gross HS
Curr Ther Res Clin Exp; 1974 Jul; 16(7):696-705. PubMed ID: 4210459
[No Abstract] [Full Text] [Related]
3. Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
O'Brien CP; DiGiacomo JN; Webb W
Dis Nerv Syst; 1974 Feb; 35(2):75-8. PubMed ID: 17894044
[TBL] [Abstract][Full Text] [Related]
4. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
Greger J; Glitschka A; Müller K
Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
[No Abstract] [Full Text] [Related]
5. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
Platz AR; Klett CJ; Caffey EM
Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216
[No Abstract] [Full Text] [Related]
6. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
Degkwitz R; Bauer MP; Gruber M; Hampel G; Luxenburger O; Richartz M; Wenzel W
Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
[No Abstract] [Full Text] [Related]
7. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
Knight RG; Harrison A
N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
[TBL] [Abstract][Full Text] [Related]
8. Relationship of individual tolerance, behavior and phenothiazine produced extrapyramidal system disturbance.
Simpson GM; Kunz-Bartholini E
Dis Nerv Syst; 1968 Apr; 29(4):269-74. PubMed ID: 5652493
[No Abstract] [Full Text] [Related]
9. [Transitory exacerbations arising during the course of neuroleptic therapy].
Gurovich IIa
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):919-25. PubMed ID: 5471621
[No Abstract] [Full Text] [Related]
10. Metiapine: a double-blind evaluation in chronic schizophrenic patients.
Gallant DM; Bishop MP; Guerrero-Figueroa R
Curr Ther Res Clin Exp; 1971 Dec; 13(12):734-6. PubMed ID: 5001741
[No Abstract] [Full Text] [Related]
11. Comparative effects of intramuscular thiothixene and trifluoperazine in psychotic patients.
Brauzer B; Goldstein BJ
J Clin Pharmacol J New Drugs; 1968; 8(6):400-3. PubMed ID: 4883787
[No Abstract] [Full Text] [Related]
12. Haloperidol--new addition to the drug treatment of schizophrenia.
Stewart A; Lafave HG; Segovia G
Behav Neuropsychiatry; 1969 Oct; 1(7):23-8. PubMed ID: 4907607
[No Abstract] [Full Text] [Related]
13. A comparative study of fluphenazine enanthate and trifluoperazine in chronic schizophrenic patients.
Bankier RG; Pettit DE; Bergen B
Dis Nerv Syst; 1968 Jan; 29(1):56-60. PubMed ID: 4865636
[No Abstract] [Full Text] [Related]
14. A double-blind comparison of pimozide vs. trifluoperazine in schizophrenic outpatients.
Claghorn JL
Curr Ther Res Clin Exp; 1974 Sep; 16(9):1005-9. PubMed ID: 4214658
[No Abstract] [Full Text] [Related]
15. Comparative short-term evaluation of penfluridol and trifluoperazine in chronic schizophrenia.
Khorana AB; Patel Y
Indian J Physiol Pharmacol; 1988; 32(4):293-8. PubMed ID: 3063660
[TBL] [Abstract][Full Text] [Related]
16. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
López Ibor JJ; Ayuso JL; Gutiérrez M; Guimon J; Herraiz ML; Chinchilla A; Ayuso JL; González Pinto A; Eguiluz I; Fernández A
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(4):165-72. PubMed ID: 8984849
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
Cocito E; Ambrosini G; Arata A; Bevilacqua P; Tortora E
Arzneimittelforschung; 1970 Aug; 20(8):1119-25. PubMed ID: 4921409
[No Abstract] [Full Text] [Related]
18. Haloperidol--a preliminary clinical study.
Holstein AP; Chen CH
Am J Psychiatry; 1965 Oct; 122(4):462-3. PubMed ID: 5825400
[No Abstract] [Full Text] [Related]
19. A twelve month comparison of penfluridol and trifluoperazine in chronic schizophrenic outpatients.
Donlon PT; Meyer JE
J Clin Psychiatry; 1978 Jun; 39(6):582-3, 686-8. PubMed ID: 350861
[TBL] [Abstract][Full Text] [Related]
20. Flupenthixol and trifluoperazine: a double-blind investigation in the treatment of schizophrenics.
Gottfries CG
Br J Psychiatry; 1971 Nov; 119(552):547-8. PubMed ID: 4944664
[No Abstract] [Full Text] [Related]
[Next] [New Search]
